Market revenue in 2023 | USD 964.4 million |
Market revenue in 2030 | USD 2,174.8 million |
Growth rate | 12.3% (CAGR from 2023 to 2030) |
Largest segment | Oncology testing |
Fastest growing segment | Genetic Testing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology Testing, Infectious Disease Testing, Genetic Testing, Endocrinology Testing, Toxicology Testing, Neurology Testing |
Key market players worldwide | Labcorp Holdings Inc, OPKO Health Inc, Quest Diagnostics Inc, Sonic Healthcare Ltd, H U Group Holdings Inc, Stanford Health Care, the mayo foundation, ARUP Laboratories, Athenahealth, Rochester Regional Health, Healius Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to esoteric testing market will help companies and investors design strategic landscapes.
Oncology testing was the largest segment with a revenue share of 27.7% in 2023. Horizon Databook has segmented the France esoteric testing market based on oncology testing, infectious disease testing, genetic testing, endocrinology testing, toxicology testing, neurology testing covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the France esoteric testing market , including forecasts for subscribers. This country databook contains high-level insights into France esoteric testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account